» Articles » PMID: 22271868

Role of Nitric Oxide and Prostanoids in the Regulation of Leg Blood Flow and Blood Pressure in Humans with Essential Hypertension: Effect of High-intensity Aerobic Training

Overview
Journal J Physiol
Specialty Physiology
Date 2012 Jan 25
PMID 22271868
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the role of nitric oxide (NO) and prostanoids in the regulation of leg blood flow and systemic blood pressure before and after 8 weeks of aerobic high-intensity training in individuals with essential hypertension (n = 10) and matched healthy control subjects (n = 11). Hypertensive subjects were found to have a lower (P < 0.05) blood flow to the exercising leg than normotensive subjects (30 W: 2.92 ± 0.16 vs. 3.39 ± 0.37 l min(−1)). Despite the lower exercise hyperaemia, pharmacological inhibition of the NO and prostanoid systems reduced leg blood flow to a similar extent during exercise in the two groups and vascular relaxation to the NO-dependent vasodilator acetylcholine was also similar between groups. High-intensity aerobic training lowered (P < 0.05) resting systolic (∼9 mmHg) and diastolic (∼12 mmHg) blood pressure in subjects with essential hypertension, but this effect of training was abolished when the NO and prostanoid systems were inhibited. Skeletal muscle vascular endothelial NO synthase uncoupling, expression and phosphorylation status were similar in the two groups before and after training. These data demonstrate that a reduction in exercise hyperaemia in hypertensive subjects is not associated with a reduced capacity of the NO and prostanoid systems to induce vasodilatation or with altered acetylcholine-induced response. However, our data suggest that the observed reduction in blood pressure is related to a training-induced change in the tonic effect of NO and/or prostanoids on vascular tone.

Citing Articles

Effects of different dietary supplements on athletic performance in soccer players: a systematic review and network meta-analysis.

Luo H, Tengku Kamalden T, Zhu X, Xiang C, Nasharuddin N J Int Soc Sports Nutr. 2025; 22(1):2467890.

PMID: 39972597 PMC: 11843665. DOI: 10.1080/15502783.2025.2467890.


The specific medications for pulmonary arterial hypertension at functional class III to IV: a systematic review and meta-analysis.

Li Q, Kuang H, Yi Q, Du H Front Med (Lausanne). 2024; 11:1448503.

PMID: 39735698 PMC: 11672201. DOI: 10.3389/fmed.2024.1448503.


Hypertension restricts leg blood flow and aggravates neuromuscular fatigue during human locomotion in males.

Thurston T, Weavil J, Wan H, Supiano M, Kithas P, Amann M Am J Physiol Regul Integr Comp Physiol. 2024; 327(5):R517-R524.

PMID: 39133778 PMC: 11563585. DOI: 10.1152/ajpregu.00117.2024.


Physical Activity and Hypertension.

Hayes P, Ferrara A, Keating A, McKnight K, ORegan A Rev Cardiovasc Med. 2024; 23(9):302.

PMID: 39077709 PMC: 11262345. DOI: 10.31083/j.rcm2309302.


10-20-30 exercise training improves fitness and health.

Bangsbo J Eur J Sport Sci. 2024; 24(8):1162-1175.

PMID: 39031952 PMC: 11295100. DOI: 10.1002/ejsc.12163.


References
1.
Proctor D, Miller J, Dietz N, Minson C, Joyner M . Reduced submaximal leg blood flow after high-intensity aerobic training. J Appl Physiol (1985). 2001; 91(6):2619-27. DOI: 10.1152/jappl.2001.91.6.2619. View

2.
Heerkens E, Izzard A, Heagerty A . Integrins, vascular remodeling, and hypertension. Hypertension. 2006; 49(1):1-4. DOI: 10.1161/01.HYP.0000252753.63224.3b. View

3.
Kalliokoski K, Oikonen V, Takala T, Sipila H, Knuuti J, Nuutila P . Enhanced oxygen extraction and reduced flow heterogeneity in exercising muscle in endurance-trained men. Am J Physiol Endocrinol Metab. 2001; 280(6):E1015-21. DOI: 10.1152/ajpendo.2001.280.6.E1015. View

4.
Joyner M, Casey D . The catecholamines strike back. What NO does not do. Circ J. 2009; 73(10):1783-92. PMC: 3760385. DOI: 10.1253/circj.cj-09-0559. View

5.
Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A . Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998; 97(22):2222-9. DOI: 10.1161/01.cir.97.22.2222. View